| Product Code: ETC9497559 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sudan Pharmacogenetic Testing Market Overview |
3.1 Sudan Country Macro Economic Indicators |
3.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Sudan Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Sudan Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Sudan Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sudan Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and the benefits of pharmacogenetic testing |
4.2.2 Growing prevalence of chronic diseases in Sudan, leading to a demand for more personalized treatment options |
4.2.3 Government initiatives to improve healthcare infrastructure and promote precision medicine |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals to conduct pharmacogenetic testing and interpret the results |
4.3.2 High cost associated with pharmacogenetic testing procedures, limiting accessibility for a significant portion of the population |
5 Sudan Pharmacogenetic Testing Market Trends |
6 Sudan Pharmacogenetic Testing Market, By Types |
6.1 Sudan Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Sudan Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Sudan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Sudan Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Sudan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Sudan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Sudan Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Sudan Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Sudan Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sudan Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Sudan Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Sudan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Sudan Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Sudan Pharmacogenetic Testing Market Export to Major Countries |
7.2 Sudan Pharmacogenetic Testing Market Imports from Major Countries |
8 Sudan Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services in Sudan |
8.2 Percentage of physicians trained in pharmacogenetics in the country |
8.3 Adoption rate of pharmacogenetic testing among healthcare providers in Sudan |
9 Sudan Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Sudan Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sudan Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Sudan Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Sudan Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here